Peapack-Gladstone Financial Corp’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.22M | Buy |
75,649
+46,535
| +160% | +$3.21M | 0.07% | 225 |
|
|
2025
Q1 | $2.02M | Buy |
29,114
+1
| +0% | +$69 | 0.03% | 330 |
|
|
2024
Q4 | $2.5M | Buy |
29,113
+957
| +3% | +$82.3K | 0.04% | 296 |
|
|
2024
Q3 | $3.35M | Buy |
28,156
+4,122
| +17% | +$491K | 0.05% | 275 |
|
|
2024
Q2 | $3.43M | Buy |
24,034
+776
| +3% | +$111K | 0.05% | 258 |
|
|
2024
Q1 | $2.99M | Buy |
23,258
+3,603
| +18% | +$463K | 0.05% | 276 |
|
|
2023
Q4 | $2.03M | Buy |
19,655
+904
| +5% | +$93.5K | 0.03% | 318 |
|
|
2023
Q3 | $1.71M | Buy |
18,751
+4,489
| +31% | +$408K | 0.03% | 316 |
|
|
2023
Q2 | $1.15M | Buy |
14,262
+4,048
| +40% | +$328K | 0.02% | 373 |
|
|
2023
Q1 | $813K | Buy |
10,214
+3,360
| +49% | +$267K | 0.02% | 408 |
|
|
2022
Q4 | $464K | Buy |
6,854
+176
| +3% | +$11.9K | 0.01% | 472 |
|
|
2022
Q3 | $333K | Sell |
6,678
-200
| -3% | -$9.97K | 0.01% | 524 |
|
|
2022
Q2 | $383K | Hold |
6,878
| – | – | 0.01% | 477 |
|
|
2022
Q1 | $382K | Hold |
6,878
| – | – | 0.01% | 516 |
|
|
2021
Q4 | $385K | Hold |
6,878
| – | – | 0.01% | 512 |
|
|
2021
Q3 | $330K | Hold |
6,878
| – | – | 0.01% | 529 |
|
|
2021
Q2 | $288K | Hold |
6,878
| – | – | 0.01% | 525 |
|
|
2021
Q1 | $232K | Hold |
6,878
| – | – | 0.01% | 537 |
|
|
2020
Q4 | $240K | Hold |
6,878
| – | – | 0.01% | 380 |
|
|
2020
Q3 | $239K | Hold |
6,878
| – | – | 0.01% | 335 |
|
|
2020
Q2 | $225K | Sell |
6,878
-1,462
| -18% | -$47.8K | 0.01% | 348 |
|
|
2020
Q1 | $251K | Buy |
8,340
+614
| +8% | +$18.5K | 0.01% | 319 |
|
|
2019
Q4 | $224K | Buy |
+7,726
| New | +$224K | 0.01% | 334 |
|